Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Tumor necrosis factor-induced modulation of glyoxalase I activities through phosphorylation by PKA results in cell death and is accompanied by the formation of a specific methylglyoxal-derived AGE.

Van Herreweghe F, Mao J, Chaplen FW, Grooten J, Gevaert K, Vandekerckhove J, Vancompernolle K.

Proc Natl Acad Sci U S A. 2002 Jan 22;99(2):949-54. Epub 2002 Jan 15.

2.

Tumour necrosis factor induces phosphorylation primarily of the nitric-oxide-responsive form of glyoxalase I.

de Hemptinne V, Rondas D, Vandekerckhove J, Vancompernolle K.

Biochem J. 2007 Oct 1;407(1):121-8.

3.

Beta-actin is required for mitochondria clustering and ROS generation in TNF-induced, caspase-independent cell death.

Li J, Li Q, Xie C, Zhou H, Wang Y, Zhang N, Shao H, Chan SC, Peng X, Lin SC, Han J.

J Cell Sci. 2004 Sep 15;117(Pt 20):4673-80.

4.

Sciadopitysin alleviates methylglyoxal-mediated glycation in osteoblastic MC3T3-E1 cells by enhancing glyoxalase system and mitochondrial biogenesis.

Choi EM, Suh KS, Rhee SY, Kim YS.

Free Radic Res. 2014 Jul;48(7):729-39. doi: 10.3109/10715762.2014.903562. Epub 2014 Apr 3.

PMID:
24628445
6.

The glyoxalase pathway: the first hundred years... and beyond.

Sousa Silva M, Gomes RA, Ferreira AE, Ponces Freire A, Cordeiro C.

Biochem J. 2013 Jul 1;453(1):1-15. doi: 10.1042/BJ20121743. Review.

PMID:
23763312
7.

Pathological effects of glyoxalase I inhibition in SH-SY5Y neuroblastoma cells.

Kuhla B, Lüth HJ, Haferburg D, Weick M, Reichenbach A, Arendt T, Münch G.

J Neurosci Res. 2006 Jun;83(8):1591-600.

PMID:
16555297
8.

Methylglyoxal suppresses TNF-alpha-induced NF-kappaB activation by inhibiting NF-kappaB DNA-binding.

Laga M, Cottyn A, Van Herreweghe F, Vanden Berghe W, Haegeman G, Van Oostveldt P, Vandekerckhove J, Vancompernolle K.

Biochem Pharmacol. 2007 Aug 15;74(4):579-89. Epub 2007 Jun 3.

PMID:
17617381
9.

Tumor necrosis factor alpha induces a caspase-independent death pathway in human neutrophils.

Maianski NA, Roos D, Kuijpers TW.

Blood. 2003 Mar 1;101(5):1987-95. Epub 2002 Oct 10.

PMID:
12393608
10.

Inhibitory effect of apocynin on methylglyoxal-mediated glycation in osteoblastic MC3T3-E1 cells.

Suh KS, Rhee SY, Kim YS, Choi EM.

J Appl Toxicol. 2015 Apr;35(4):350-7. doi: 10.1002/jat.3016. Epub 2014 Jul 18.

PMID:
25042521
11.
12.

Tumor necrosis factor-induced microtubule stabilization mediated by hyperphosphorylated oncoprotein 18 promotes cell death.

Vancompernolle K, Boonefaes T, Mann M, Fiers W, Grooten J.

J Biol Chem. 2000 Oct 27;275(43):33876-82.

13.

Increased glyoxalase I levels inhibit accumulation of oxidative stress and an advanced glycation end product in mouse mesangial cells cultured in high glucose.

Kim KM, Kim YS, Jung DH, Lee J, Kim JS.

Exp Cell Res. 2012 Jan 15;318(2):152-9. doi: 10.1016/j.yexcr.2011.10.013. Epub 2011 Oct 21.

PMID:
22036650
14.
15.

Methylglyoxal induces oxidative stress and mitochondrial dysfunction in osteoblastic MC3T3-E1 cells.

Suh KS, Choi EM, Rhee SY, Kim YS.

Free Radic Res. 2014 Feb;48(2):206-17. doi: 10.3109/10715762.2013.859387. Epub 2013 Nov 18.

PMID:
24164256
16.
17.

Female reproductive dysfunction during ageing: role of methylglyoxal in the formation of advanced glycation endproducts in ovaries of reproductively-aged mice.

Tatone C, Carbone MC, Campanella G, Festuccia C, Artini PG, Talesa V, Focarelli R, Amicarelli F.

J Biol Regul Homeost Agents. 2010 Jan-Mar;24(1):63-72.

PMID:
20385072
18.

Phosphorylation on Thr-106 and NO-modification of glyoxalase I suppress the TNF-induced transcriptional activity of NF-kappaB.

de Hemptinne V, Rondas D, Toepoel M, Vancompernolle K.

Mol Cell Biochem. 2009 May;325(1-2):169-78. doi: 10.1007/s11010-009-0031-7. Epub 2009 Feb 6.

PMID:
19199007
19.

Redox regulation of TNF signaling.

Goossens V, De Vos K, Vercammen D, Steemans M, Vancompernolle K, Fiers W, Vandenabeele P, Grooten J.

Biofactors. 1999;10(2-3):145-56. Review.

PMID:
10609876
20.

[The role of methylglyoxal metabolism in type-2 diabetes and its complications].

Kender Z, Torzsa P, Grolmusz K V, Patócs A, Lichthammer A, Veresné Bálint M, Rácz K, Reismann P.

Orv Hetil. 2012 Apr 15;153(15):574-85. doi: 10.1556/OH.2012.29348. Review. Hungarian.

PMID:
22472358

Supplemental Content

Support Center